Li Chen-Sheng, Wan De-Sen, Pan Zhi-Zhong, Zhou Zhi-Wei, Chen Gong, Wu Xiao-Jun, Li Li-Ren, Lu Zhen-Hai, Ding Pei-Rong, Li Yong
State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, 510060, P. R. China.
Ai Zheng. 2006 May;25(5):587-90.
BACKGROUND & OBJECTIVE: The incidence of low and middle rectal cancer is high in China. Researches on improving treatment efficacy of this disease have constantly been concerned. This study was to evaluate the correlation of clinicopathologic features to the prognosis in low and middle rectal cancer.
The clinicopathologic data of 599 patients with low and middle rectal cancer, treated from 1990 to 1999 in Cancer Center of Sun Yat-sen University, were analyzed retrospectively. Curative resection was performed for all patients, including abdominoperineal resection (ARP, 355 cases) and low anterior resection (LAR, 244 cases). Survival rate was calculated using life table method, and differences between survival curves were tested by log-rank test. Cox regression model was used for multivariate prognostic analysis.
The overall 5-year survival rate was 70.7%; it was significantly lower in APR group than in LAR group (67.5% vs. 75.2%, P=0.026). Univariate analysis showed that local recurrence, perioperative blood transfusion, lymph node metastasis, T stage, histology, macropathology, operation pattern, and distance from anal margin were correlated to prognosis (P<0.05). Multivariate analysis showed that local recurrence, perioperative blood transfusion, lymph node metastasis, and T stage were independent prognostic factors (P<0.01).
Local recurrence, perioperative blood transfusion, lymph node metastasis, and T stage are important prognostic factors of low and middle rectal cancer. LAR has become the preferred option in curative surgery for low and middle rectal cancer.
中国中低位直肠癌发病率较高,提高其治疗效果的研究一直备受关注。本研究旨在评估中低位直肠癌临床病理特征与预后的相关性。
回顾性分析1990年至1999年在中山大学肿瘤防治中心接受治疗的599例中低位直肠癌患者的临床病理资料。所有患者均行根治性手术,包括腹会阴联合切除术(ARP,355例)和低位前切除术(LAR,244例)。采用寿命表法计算生存率,生存曲线差异采用log-rank检验。采用Cox回归模型进行多因素预后分析。
总体5年生存率为70.7%;ARP组显著低于LAR组(67.5%对75.2%,P = 0.026)。单因素分析显示,局部复发、围手术期输血、淋巴结转移、T分期、组织学类型、大体病理类型、手术方式及距肛缘距离与预后相关(P < 0.05)。多因素分析显示,局部复发、围手术期输血、淋巴结转移及T分期是独立的预后因素(P < 0.01)。
局部复发、围手术期输血、淋巴结转移及T分期是中低位直肠癌重要的预后因素。LAR已成为中低位直肠癌根治性手术的首选术式。